Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2008-5-2
pubmed:abstractText
This study compared the costs of antipsychotic polypharmacy for patients who initiated on 1 of the 3 most commonly prescribed atypical antipsychotics - olanzapine, quetiapine, or risperidone.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-10217396, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-10453794, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-10572323, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-11387789, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-11874226, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-12047009, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-12047017, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-12047024, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-12366465, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-12509667, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-12616846, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-12765741, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-12795493, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-12841799, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-14578539, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-14720128, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-15000267, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-15056517, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-15093956, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-15176758, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-15491242, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-15899104, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-15921508, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-16401150, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-16889456, http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-17070017
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1471-244X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
19
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Cost of antipsychotic polypharmacy in the treatment of schizophrenia.
pubmed:affiliation
Eli Lilly and Company, Indianapolis, Indiana, USA. zhu_baojin@lilly.com
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't, Multicenter Study